logo
AbbVie (ABBV) Soared on Favorable Tailwinds

AbbVie (ABBV) Soared on Favorable Tailwinds

Yahoo20-05-2025
Carillon Tower Advisers, an investment management company, released its 'Carillon Eagle Growth & Income Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index ended Q1 down 4.3%, marking a turbulent start to 2025. The volatility that began in February was triggered by factors including policy uncertainties, economic deceleration, and AI investment sustainability concerns. The market's first intra-quarter drawdown exceeded 10% in 28 months. Adding to the uncertainty, the 10-year U.S. Treasury yield declined from 4.8% to 4.25%, leading to an equity market rotation favoring defensive sectors, quality stocks, and dividend-yielding equities over growth and momentum-driven investments, with top-performing sectors like energy, healthcare, and consumer staples. Moreover, the quarter saw market participation broaden, with index leadership shifting from mega-cap technology companies to a more diverse base of stocks, as evidenced by the S&P 500® Equal Weight Index's outperformance. Additionally, you can check the fund's top 5 holdings to determine its best picks for 2025.
In its first-quarter 2025 investor letter, Carillon Eagle Growth & Income Fund highlighted stocks such as AbbVie Inc. (NYSE:ABBV). AbbVie Inc. (NYSE:ABBV) is a research-based biopharmaceutical company. The one-month return of AbbVie Inc. (NYSE:ABBV) was 6.74%, and its shares gained 13.84% of their value over the last 52 weeks. On May 19, 2025, AbbVie Inc. (NYSE:ABBV) stock closed at $185.71 per share with a market capitalization of $327.809 billion.
Carillon Eagle Growth & Income Fund stated the following regarding AbbVie Inc. (NYSE:ABBV) in its Q1 2025 investor letter:
"AbbVie Inc. (NYSE:ABBV) issued better than expected initial 2025 guidance and raised the long-term sales outlook for its two most important drugs. The stock also benefited from the broader equity market rotation into the healthcare sector, including into more defensive industries like biopharmaceuticals."
A pharmacist handing out a pharmaceutical drug to a patient in a drug store or chemist.
AbbVie Inc. (NYSE:ABBV) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 85 hedge fund portfolios held AbbVie Inc. (NYSE:ABBV) at the end of the fourth quarter, compared to 68 in the third quarter. While we acknowledge the potential of AbbVie Inc. (NYSE:ABBV) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains.
In another article, we covered AbbVie Inc. (NYSE:ABBV) and shared the list of best dividend stocks with high yields. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors.
READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks.
Disclosure: None. This article is originally published at Insider Monkey.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim
AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim

Yahoo

time26 minutes ago

  • Yahoo

AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim

AT&T Inc. (NYSE:T) customers, both present and past, stand to receive up to $7,500 as part of a proposed $177 million settlement. This settlement is in response to two significant data breaches that affected millions of AT&T customers. What Happened: AT&T Inc. has suggested a settlement amounting to $177 million. This sum includes $149 million for the initial class-action lawsuit and an additional $28 million for the second one. The first data breach, revealed in March 2024, impacted 73 million account holders, with hackers obtaining personal information and disseminating it on the dark web. A subsequent breach in July 2024 compromised the call and text records of almost all AT&T customers. According to the report by New York Post, the settlement is yet to receive approval, with a final hearing set for December 3 in the US District Court for the Northern District of Texas. Customers who had their data compromised can apply for compensation before the hearing. They will be notified via an email from Kroll Settlement Administration and must submit a claim form by November 18. Also Read: GameStop to Pay $4.5 Million Over Alleged Privacy Violations Involving Facebook Data Sharing Customers affected by the March 2024 breach can claim up to $5,000, while those impacted by the July breach can claim up to $2,500. Customers who were affected by both breaches could be eligible for up to $7,500. AT&T will require evidence of losses associated with the breaches. Payouts are anticipated to commence by the end of the year, but may be postponed if appeals are lodged after the hearing. Why It Matters: This settlement proposal comes as a significant development for AT&T customers who were affected by the data breaches. The proposed compensation not only acknowledges the inconvenience and potential harm caused by the breaches, but also serves as a reminder of the importance of robust data security measures for companies handling sensitive customer information. The outcome of the final hearing will be closely watched, as it could set a precedent for future data breach settlements. Read Next Wall Street's Most Accurate Analysts Give Their Take On 3 Tech And Telecom Stocks Delivering High-Dividend Yields UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? AT&T (T): Free Stock Analysis Report This article AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio

Benchmark Co. Maintains a Buy Rating on HNI Corporation (HNI)
Benchmark Co. Maintains a Buy Rating on HNI Corporation (HNI)

Yahoo

time36 minutes ago

  • Yahoo

Benchmark Co. Maintains a Buy Rating on HNI Corporation (HNI)

HNI Corporation (NYSE:HNI) is one of the best small cap low volatility stocks to invest in. On August 5, Benchmark Co. analyst Reuben Garner maintained a Buy rating on HNI Corporation (NYSE:HNI) and set a price target of $60.00. A worker in a warehouse packaging a modern storage furniture. The rating update came after HNI Corporation (NYSE:HNI) announced on August 4 that it entered into a definitive agreement with Steelcase Inc. Under the terms of the agreement, HNI Corporation (NYSE:HNI) would acquire Steelcase in a 'cash and stock transaction, with a total consideration of approximately $2.2 billion to Steelcase common shareholders'. HNI Corporation (NYSE:HNI) provides workplace furnishings and residential building products. Its operations are divided into the Residential Building Products and Workplace Furnishing segments. The company's brand portfolio includes Beyond, HON, Kimball, HBF Textiles, HNI India, and more. Through its export subsidiary, HNI Corporation (NYSE:HNI) exports certain products to North America, principally Latin America, the Caribbean, and Mexico. While we acknowledge the potential of HNI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

KBW Reiterates a Hold Rating on Bank of NT Butterfield & Son (NTB)
KBW Reiterates a Hold Rating on Bank of NT Butterfield & Son (NTB)

Yahoo

time36 minutes ago

  • Yahoo

KBW Reiterates a Hold Rating on Bank of NT Butterfield & Son (NTB)

Bank of NT Butterfield & Son Ltd. (NYSE:NTB) is one of the best small cap low volatility stocks to invest in. On July 29, KBW analyst Tim Switzer maintained a Hold rating on Bank of NT Butterfield & Son Ltd. (NYSE:NTB) and set a price target of $50.00. A close-up of a borrower signing off a loan with a smile on their face. The rating update came after Bank of NT Butterfield & Son Ltd. (NYSE:NTB) reported its fiscal Q2 2025 earnings on July 28, with net income for the quarter reaching $53.3 million and core net income of $53.7 million, or $1.26 per share. Management reported a return on average common equity of 20.3% and a core return on average tangible common equity of 22.3%. Bank of NT Butterfield & Son Ltd. (NYSE:NTB) also repurchased 1.1 million shares at an average price of $40.69 per share. Bank of NT Butterfield & Son Ltd. (NYSE:NTB) provides community banking and wealth management business. The company's operations are divided into the following geographical segments: Bermuda, the Cayman Islands, Channel Islands and the UK, and Other. While we acknowledge the potential of NTB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store